Literature DB >> 30076024

Improving adherence to recommended venous thromboembolic prophylaxis in abdominal and pelvic oncologic surgery.

Monica Zipple1, Edwin Itenberg2.   

Abstract

BACKGROUND: We reviewed rates of adherence to the American College of Chest Physicians guidelines for venous thromboembolism prophylaxis in abdominal and pelvic oncologic surgery at our community hospital compared with rates statewide.
METHODS: We completed a retrospective review of adult patients undergoing abdominal or pelvic oncologic surgery from January 1, 2015 to December 31, 2016, compared with statewide data from the Michigan Surgical Quality Collaborative during the same period. Educational intervention included creation of hospital guidelines and presentations reviewing American College of Chest Physicians guidelines and hospital adherence rates. A short-term observation of extended-duration venous thromboembolism prophylaxis rates was completed after the intervention.
RESULTS: The rates of in-hospital venous thromboembolism prophylaxis (general surgery: 93.7%, n = 106; gynecology: 40.0%, n = 32) were comparable to statewide in-hospital prophylaxis rates (89.6% general surgery, 41.8% gynecology). Five patients (4.5%) were prescribed extended-duration prophylaxis, which was lower than statewide rates (20.3%). In comparison, there was a statistically significant improvement in the rate of extended prophylaxis in the 6 months following intervention to 23.6% (n = 5, P < .0005).
CONCLUSION: The rates of extended-duration venous thromboembolism prophylaxis prescription were lower than the state average at our community hospital; however, the short-term evaluation revealed significant improvement after intervention. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30076024     DOI: 10.1016/j.surg.2018.06.023

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  1 in total

1.  Extended duration chemoprophylaxis for venous thromboembolism following abdominopelvic oncologic surgery.

Authors:  John Kanitra; John Holtrop; Ali Jawad; Richard Berri
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.